METASTATIC SOLID TUMOR
Clinical trials for METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new pill outsmart RAS-Mutant cancers?
Disease control Not yet recruitingThis early-stage trial is testing an experimental oral drug called BG-85738 in people with advanced or metastatic solid tumors that have RAS mutations. The study aims to see if the drug is safe and tolerable when given alone or combined with other anti-cancer agents, and to get a…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can a smart drug deliver a toxic payload directly to cancer cells?
Disease control Not yet recruitingThis early-phase trial is testing an experimental antibody-drug conjugate called MC002 in adults with advanced solid tumors, such as esophageal or lung cancer, that have progressed after standard treatments. MC002 is designed to target a protein found on cancer cells and deliver …
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Hangzhou MacroLink Biopharmaceutical LLC • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New cancer pill enters first human tests
Disease control Not yet recruitingThis early-phase trial tests an experimental drug called ISM5939, taken as a pill, in people with advanced or metastatic solid tumors that have not responded to standard treatments. The study will first test the drug alone, then in combination with chemotherapy (cisplatin or doce…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: InSilico Medicine Hong Kong Limited • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug KIVU-305 takes aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis early-phase study tests a new drug called KIVU-305 in people with advanced solid tumors that have stopped responding to standard treatments. The drug is designed to target and attack cancer cells while sparing healthy ones. The main goal is to find a safe dose and see if the…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Kivu Bioscience Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Can early radiation stop cancer bone breaks?
Disease control Not yet recruitingThis study tests whether giving radiation early to bone spots where cancer has spread can prevent complications like fractures or spinal cord pressure. About 90 adults with solid cancers that have spread to up to five bones will either get standard care or standard care plus radi…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE2 • Sponsor: Institute of Oncology Ljubljana • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New drug ITC-6146RO enters first human tests for tough cancers
Disease control Not yet recruitingThis early-phase trial tests an experimental drug called ITC-6146RO in about 102 adults with advanced or metastatic cancers (like prostate, lung, or breast cancer) that have not improved with standard treatments. The study has two parts: first, finding a safe dose, then checking …
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: IntoCell, Inc • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Can a stronger radiation dose ease bulky tumors better?
Symptom relief Not yet recruitingThis study compares standard palliative radiotherapy (24 Gray in 3 sessions) with a higher dose (27 Gray in 3 sessions) for people with large metastatic tumors. The goal is to see if the higher dose improves tumor control without more side effects. About 20 adults with solid tumo…
Matched conditions: METASTATIC SOLID TUMOR
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Fighting cancer wasting: can diet and exercise make olanzapine work better?
Symptom relief Not yet recruitingThis trial tests whether adding a structured nutrition and exercise program to the standard appetite-stimulating drug olanzapine can improve quality of life in people with advanced solid tumors who have poor appetite. Participants are randomly assigned to receive olanzapine alone…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE2 • Sponsor: Kantonsspital Winterthur KSW • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can remote check-ins and telehealth improve quality of life for advanced cancer patients?
Symptom relief Not yet recruitingThis trial tests a program that combines palliative care with remote monitoring and telehealth to better support people with advanced cancer. Participants complete questionnaires and physical exams, and their care is tailored to their needs. The study includes 300 adults with met…
Matched conditions: METASTATIC SOLID TUMOR
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC